Adani Commodities, a promoter entity of Adani Wilmar, will sell up to a 20% stake in the company through an Offer For Sale (OFS) scheduled for January 10 and 13. The floor price for the sale has been set at ₹275 per share, according to a company filing on January 9. Adani Wilmar’s shares closed […]
Adani Wilmar’s OFS for 20% Stake Opens January 10 at ₹275 Floor Price Read More »
Tata Consultancy Services (TCS) reported a 12% rise in consolidated net profit for Q3 FY25, reaching ₹12,380 crore compared to ₹11,058 crore in the same quarter last year, surpassing market estimates. The company’s consolidated revenue grew by 6% year-on-year to ₹63,973 crore from ₹60,583 crore, although it fell short of projections. Sequentially, TCS’s net profit
TCS Q3 Results: Net Profit Jumps 12% to ₹12,380 Crore; ₹66 Special Dividend Announced Read More »
Shares of Advait Energy saw a 1.5% rise in early trading on January 9 after the company secured a significant Letter of Intent (LoI) from Gujarat Urja Vikas Nigam (GUVNL) for a 50 MW battery storage project. On the BSE, Advait Infratech Limited was trading at Rs 1,552.00 at 09:33 AM, up by Rs 22.35
Advait Energy Shares Gain on Letter of Intent from Gujarat Urja Vikas Nigam Read More »
Foxconn Technology Group and Dixon Technologies India Ltd., key players in India’s electronics manufacturing drive, have urged the government to release pending subsidies under the production-linked incentive (PLI) scheme. These subsidies, part of the Rs 41,000 crore ($4.8 billion) package, aim to encourage large-scale manufacturing in India but remain partially unallocated due to unmet production
Foxconn, Dixon Seek Pending Subsidies Under Production Incentive Scheme Read More »
The National Stock Exchange (NSE) has announced a major expansion of its co-location services, further establishing itself as one of the largest co-location service providers worldwide. It has added more than 200 Full Rack Equivalent capacities under Colocation Phases 11 and 12 at its NSEIL premises. This takes the total capacity to over 1,200 FREs
NSE Expands Co-Location Capacity, Strengthens Global Presence Read More »
Tencent Holdings Ltd., China’s most valuable technology firm, conducted its biggest share repurchase in almost two decades following a sharp stock decline. The selloff occurred after Tencent was added to a US blacklist for alleged ties to the Chinese military. On Tuesday alone, the company bought back 3.93 million Hong Kong-listed shares worth HK$1.5 billion
Tencent Executes Largest Share Buyback Since 2006 Amid US Blacklist Concerns Read More »
The National Stock Exchange of India (NSE) has announced the inclusion of six new securities in the Futures and Options (F&O) segment starting January 31, 2025. The stocks to be added are Castrol India, Gland Pharma, NBCC, Phoenix Mills, Solar Industries India, and Torrent Power. These stocks have been selected as per the criteria prescribed
NSE to Add Six New Stocks to F&O Segment from January 31, 2025 Read More »
India’s economy is projected to grow at 6.4% in FY25, marking its lowest growth rate in four years, according to the government’s first advance estimates released on January 7. This would be the first time in four years that GDP growth falls below the 7% threshold. The economy performed well in Q1 of the FY25
India’s GDP Growth May Slow to Four-Year Low of 6.4% in FY25: Government Estimates Read More »
Fintech company One MobiKwik Systems Ltd. reported a net loss of ₹3.6 crore for the September 2024 quarter, reversing a net profit of ₹5.3 crore in the same period last fiscal. The loss was attributed to an increase in expenses, the company said in an exchange filing on January 7. Despite the loss, operational revenue
MobiKwik Posts ₹3.6 Crore Net Loss in Q2 Amid Rising Expenses; Revenue Grows 43% Read More »
Shares of Zydus Lifesciences surged over 5% on January 7 following the announcement of a strategic agreement with US-based healthcare firm CVS Caremark. The collaboration will see Zydus’ diabetes products included in CVS Caremark’s template formulary, enhancing access to these treatments in the US market. The agreement covers Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride),
Zydus Lifesciences Gains 5% After Securing Deal with CVS Caremark for Diabetes Products Read More »
